Index Entries

1995 Results
TitleIS Publication Date
Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance systemOctober 16, 2021
Real Not Rare
Real REACTIONS - Non-profit support organization for the vaccine injured
Real-Time Self-Assembly of Stereomicroscopically Visible Artificial Constructions in Incubated Specimens of mRNA Products Mainly from Pfizer and Moderna: A Comprehensive Longitudinal StudyJuly 18, 2024
Real-world evidence from over one million COVID-19 vaccinations is consistent with reactivation of the varicella-zoster virusMay 13, 2022
Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-CoronavirusAugust 2, 2019
Recent progress of graphene oxide as a potential vaccine carrier and adjuvantAugust 2020
Reconciling estimates of global spread and infection fatality rates of COVID-19: An overview of systematic evaluationsMarch 26, 2021
Recurrence of Autoimmune Hepatitis After COVID-19 VaccinationMay 25, 2022
Recurrent Myocarditis Following COVID-19 Infection and the mRNA VaccineJuly 7, 2022
Reducing SARS-CoV-2 transmission in the UK: A behavioural science approach to identifying options for increasing adherence to social distancing and shielding vulnerable peopleMay 19, 2020
Regular Use of Ivermectin as Prophylaxis for COVID-19 Led Up to a 92% Reduction in COVID-19 Mortality Rate in a Dose-Response Manner: Results of a Prospective Observational Study of a Strictly Controlled Population of 88,012 SubjectsAugust 31, 2022
Regulation of Proinflammatory Molecules and Tissue Factor by SARS-CoV-2 Spike Protein in Human Placental Cells: Implications for SARS-CoV-2 Pathogenesis in Pregnant WomenApril 7, 2022
Reinfection Rates Among Patients Who Previously Tested Positive for Coronavirus Disease 2019: A Retrospective Cohort StudyMarch 15, 2021
Remdesivir and Acute Renal Failure: A Potential Safety Signal From Disproportionality Analysis of the WHO Safety DatabaseDecember 19, 2020
Remdesivir for COVID-19: real-time meta analysis of 79 studiesUpdated January 2025
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trialApril 29, 2020
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trialSeptember 14, 2021
Renal Complications Following COVID-19 Vaccination: A Narrative Literature ReviewApril 7, 2023
Repeated COVID-19 Vaccination as a Poor Prognostic Factor in Pancreatic Cancer: A Retrospective, Single-Center Cohort StudyJune 16, 2025
Reply to Fung et al. on COVID‐19 vaccine case‐countingwindow biases overstating vaccine effectivenessJuly 4, 2023
Report 12: The Global Impact of COVID-19 and Strategies for Mitigation and SuppressionMarch 26, 2020
Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demandMarch 16, 2020
Report an Adverse Event to VAERS
Reporting of Adverse Events in Published and Unpublished Studies of Health Care Interventions: A Systematic ReviewSeptember 20, 2016
Reports of acute adverse events in mRNA COVID‑19 vaccine recipients after the first and second doses in JapanSeptember 15, 2022
Reports Of Autopsies In VAERS And Associated Adverse Events Linked To Cause Of DeathFebruary 4, 2025
Reports of Batch-Dependent Suspected Adverse Events of the BNT162b2 mRNA COVID-19 Vaccine: Comparison of Results from Denmark and SwedenAugust 19, 2024
Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United StatesFebruary 1, 2023
Repurposing Ivermectin for COVID-19: Molecular Aspects and Therapeutic PossibilitiesMarch 30, 2021
Research Letter re. 'Association of herpes zoster with COVID-19 vaccination: A systematic review and meta-analysis'March 29, 2023
Research Letter: Acute Allergic Reactions to mRNA COVID-19 VaccinesMarch 8, 2021
Research Letter: All-Cause Excess Mortality and COVID-19 - Related Mortality Among US Adults Aged 25-44 Years, March-July 2020December 16, 2020
Research Letter: Assessment of SARS-CoV-2 Reinfection 1 Year After Primary Infection in a Population in Lombardy, ItalyMay 28, 2021
Research Letter: Detection of Messenger RNA COVID-19 Vaccines in Human Breast MilkSeptember 26, 2022
Research Letter: Routine Surveillance and Vaccination on a University Campus During the Spread of the SARS-CoV-2 Omicron VariantMay 18, 2022
Researchers studying reported menstrual changes after COVID-19 vaccinationJuly 8, 2021
Reset the Table: Meeting the Moment to Transform the U.S. Food SystemJuly 28, 2020
Resignation in protest, Frontiers in Pharmacology - Topic Editors, “Treating COVID-19 With Currently Available Drugs”April 23, 2021
Responding to Covid‐19: How to Navigate a Public Health Emergency Legally and EthicallyMarch 26, 2020
Response to Critics of Lee & Broudy (2024) on the Toxicity and Self-Assembling Technology in Incubated Samples of InjectaSeptember 17, 2024
Response to Request for Information (RFI): COVID-19 Misinformation from Official Sources During the PandemicMay 2, 2022
Response: Ed Humpherson to Norman Fenton, Martin Neil, Clare Craig and Scott McLachlan: ONS Deaths by Vaccination Status statisticsJanuary 23, 2023
Results of a systematic review and meta‑analysis of early studies on ivermectin in SARS‑CoV‑2 infectionMarch 7, 2023
Results of an Open Prospective Controlled Comparative Study on the Treatment of Novel Coronavirus Infection (COVID-19): Bromhexine & Spironolactone for the Treatment of Coronavirus Infection Requiring HospitalizationMay 11, 2020
Resveratrol Inhibits HCoV-229E and SARS-CoV-2 Coronavirus Replication In VitroFebruary 23, 2021
Retracted Covid-19 articles: significantly more cited than other articles within their journal of originApril 12, 2023
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis of Early COVID-19 and Treated at Home Within 3 Days or After 3 Days of Symptom Onset with Prescribed and Non-Prescribed Treatments Between November 2December 30, 2021
Return to Wuhan: What Life Is Like One Year LaterJanuary 24, 2021
Revealed: PR firm that represents Pfizer and Moderna also sits on CDC vaccine division - sparking major conflict of interest concernsOctober 12, 2022